Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy with non-valvular atrial fibrillation

Hypertrophic cardiomyopathy (HCM) patients with nonvalvular atrial fibrillation (AF) have an increased risk of suffering thromboembolic events. Vitamin K antagonists (VKA) are recommended as therapy but there is still limited data regarding the efficacy of prescribing non-vitamin K antagonist oral a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Heart and vessels 2022-07, Vol.37 (7), p.1224-1231
Hauptverfasser:	Lin, Yunchai, Xiong, Hongping, Su, Jinzi, Lin, Jinxiu, Zhou, Qiang, Lin, Meihua, Zhao, Wenxiang, Peng, Feng
Format:	Artikel
Sprache:	eng
Schlagworte:	Antagonists Anticoagulants Biomedical Engineering and Bioengineering Bleeding Cardiac arrhythmia Cardiac Surgery Cardiology Cardiomyopathy Death Fibrillation Medicine Medicine & Public Health Mortality Multiple regression analysis Original Article Patients Phylloquinone Risk Safety Survival analysis Therapy Thromboembolism Vascular Surgery Vitamin K Warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!